Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Vitamin D Supplementation on Myocardial Fibrosis in Patients with Acute Myocarditis (EDIT-AM)
2025-523092-33-00Phase 3Authorised
- Sponsor
- Sociedad Española de Cardiología
- Start
- Jul 2026
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of calcifediol in acute myocarditis and cardiac fibrosis (2 arms), sponsored by Sociedad Española de Cardiología. Primary endpoint: Extent of myocardial fibrosis by LGE at month 6. Planned start Jul 2026; status: authorised.
02
Drugs
calcifediol
03
Conditions
acute myocarditiscardiac fibrosis
Beyond the preview
Go deeper on 2025-523092-33-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2025-523092-33-00.